Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
作者信息
Guarino Maria, Cossiga Valentina, Esposito Ilaria, Furno Alessandro, Morisco Filomena
机构信息
Department of Clinical Medicine and Surgery, Gastroenterology and Hepatology Unit, University of Naples "Federico II", Naples, Italy.
Department of Clinical Medicine and Surgery, Gastroenterology and Hepatology Unit, University of Naples "Federico II", Naples, Italy.
出版信息
J Hepatol. 2022 Jan;76(1):237-239. doi: 10.1016/j.jhep.2021.07.034. Epub 2021 Aug 3.
Abstract
摘要
相似文献
1
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
J Hepatol. 2022 Jan;76(1):237-239. doi: 10.1016/j.jhep.2021.07.034. Epub 2021 Aug 3.
2
Reply to: "Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!".
J Hepatol. 2022 Jan;76(1):239-240. doi: 10.1016/j.jhep.2021.09.037. Epub 2021 Oct 8.
3
COVID-19 vaccination immune paresis in heart and lung transplantation.
J Heart Lung Transplant. 2021 Aug;40(8):763-766. doi: 10.1016/j.healun.2021.04.018. Epub 2021 May 13.
4
Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
Z Gastroenterol. 2021 Dec;59(12):1288-1296. doi: 10.1055/a-1649-8568. Epub 2021 Oct 20.
5
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
6
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
7
Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination.
J Med Virol. 2021 Dec;93(12):6474. doi: 10.1002/jmv.27263. Epub 2021 Aug 12.
8
[Rapid guideline for COVID-19 vaccination in patients with chronic liver diseases, hepatolbiliary malignancy and liver transplant].
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):523-526. doi: 10.3760/cma.j.cn501113-20210612-00278.
9
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
10
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115565. doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.
引用本文的文献
1
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors.
Vaccines (Basel). 2025 Mar 26;13(4):352. doi: 10.3390/vaccines13040352.
2
How does geographical diversity shape vaccine efficacy?
Clin Exp Vaccine Res. 2024 Oct;13(4):271-300. doi: 10.7774/cevr.2024.13.4.271. Epub 2024 Oct 31.
3
Seroconversion and safety of Covid-19 vaccines in pa-tients with chronic liver disease and liver transplant: A systematic review.
Qatar Med J. 2023 Dec 12;2023(3):21. doi: 10.5339/qmj.2023.21. eCollection 2023.
4
Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients.
Transplant Direct. 2023 Sep 20;9(10):e1537. doi: 10.1097/TXD.0000000000001537. eCollection 2023 Oct.
5
The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients.
Pathogens. 2023 Jul 5;12(7):910. doi: 10.3390/pathogens12070910.
6
Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave.
Viruses. 2023 Jan 20;15(2):297. doi: 10.3390/v15020297.
7
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.
J Hepatol. 2023 May;78(5):1017-1027. doi: 10.1016/j.jhep.2023.02.007. Epub 2023 Feb 18.
8
SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort.
Virol J. 2023 Feb 11;20(1):28. doi: 10.1186/s12985-023-01978-4.
9
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
Viruses. 2022 Oct 19;14(10):2299. doi: 10.3390/v14102299.
10
Liver transplantation during COVID-19: Adaptive measures with future significance.
World J Transplant. 2022 Sep 18;12(9):288-298. doi: 10.5500/wjt.v12.i9.288.
Zotero 插件